https://nextstage-saga.net/ Fundamentals Explained
Apotex alleged that certain US courtroom judgments and FDA decisions discriminated versus it, denied it minimum common of remedy and expropriated its investment decision in pravastatin. Damages sought: US$eight million.That lawsuit is ongoing with pending motions for summary judgment submitted by either side. Development is scheduled to start in Ap